| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/22/2005 | CN1207030C Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity |
| 06/22/2005 | CN1207023C Medical ointment for treating prostatitis and use method |
| 06/22/2005 | CN1207014C Chinese medicine compound preparation for treating enuresis and preparing process thereof |
| 06/22/2005 | CN1207000C :Roxoithromycin suppostory and its prepn. |
| 06/21/2005 | US6909014 Intermediates for the synthesis of ether compounds |
| 06/21/2005 | US6909007 Steroidal pharmaceutical compounds |
| 06/21/2005 | US6908944 Using 1-phenyl-4-(dimethylaminomethyl)cyclohexane |
| 06/21/2005 | US6908943 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/21/2005 | US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 06/21/2005 | US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors |
| 06/21/2005 | US6908920 Pyrimidine derivatives |
| 06/21/2005 | US6908741 Receptor for advanced glycated endproducts (RAGE); solid phase synthesis; immunoassay |
| 06/21/2005 | US6908609 Removing fluid from the intestinal tract of a host by directly delivering an effective amount of water-absorbent polymer to the intestinal tract |
| 06/21/2005 | CA2066304C Pharmaceutical composition for the treatment of autoimmune diseases |
| 06/16/2005 | WO2005054432A2 Gene transfer for regulating smooth muscle tone |
| 06/16/2005 | WO2005054252A1 Crystal of hydrochloride of sulfoxide derivative |
| 06/16/2005 | WO2005004989A3 Film comprising therapeutic agents |
| 06/16/2005 | WO1990006121A8 Method for improving reproductive functions in mammals |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050131049 Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence |
| 06/16/2005 | US20050131047 cardiovascular disorders |
| 06/16/2005 | US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 06/16/2005 | US20050131035 Medicaments |
| 06/16/2005 | US20050131023 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori |
| 06/16/2005 | US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity |
| 06/16/2005 | US20050130982 4-isopropyl-2-methoxy-7-[4-(2-pyrimidyl)piperazinomethyl]-2,4,6-cycloheptatrien-1-one |
| 06/16/2005 | US20050130981 Compounds |
| 06/16/2005 | US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis |
| 06/16/2005 | US20050130935 Combination of a beta-2-adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 06/16/2005 | US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer |
| 06/16/2005 | US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 06/16/2005 | US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders |
| 06/16/2005 | US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening |
| 06/16/2005 | US20050129736 Compositions and methods for treating or preventing diseases of body passageways |
| 06/16/2005 | CA2547887A1 Protein modifier production inhibitor |
| 06/16/2005 | CA2547618A1 Botulinum toxin treatment |
| 06/15/2005 | EP1541672A1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 06/15/2005 | EP1541578A1 Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides |
| 06/15/2005 | EP1541574A1 Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient |
| 06/15/2005 | EP1541573A1 Novel crystals of triazaspiro 5.5 undecane derivative |
| 06/15/2005 | EP1541571A1 Bicyclic unsaturated tertiary amine compound |
| 06/15/2005 | EP1541563A1 Ccr4 antagonist and medicinal use thereof |
| 06/15/2005 | EP1541554A1 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 06/15/2005 | EP1541174A1 Drug or cosmetic |
| 06/15/2005 | EP1541149A1 Phosphodiesterase inhibitor |
| 06/15/2005 | EP1539942A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 06/15/2005 | EP1539933A2 Methods of organ regeneration |
| 06/15/2005 | EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 06/15/2005 | EP1539763A1 Azaindole kinase inhibitors |
| 06/15/2005 | EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors |
| 06/15/2005 | EP1539739A1 Piperidinyl compounds that selectively bind integrins |
| 06/15/2005 | EP1539701A1 Caspase inhibitors and uses thereof |
| 06/15/2005 | EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators |
| 06/15/2005 | EP1539693A1 Cannabinoid receptor agonists |
| 06/15/2005 | EP1539687A1 Substituted glycine derivatives for use as medicaments |
| 06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |
| 06/15/2005 | EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 06/15/2005 | EP1539674A1 Amino-propanol derivatives |
| 06/15/2005 | EP1539662A1 Cannabinoid receptor ligands |
| 06/15/2005 | EP1539181A2 Method of treating lower urinary tract disorders |
| 06/15/2005 | EP1538913A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 06/15/2005 | EP1538888A2 Upper hitch link |
| 06/15/2005 | EP1439831B1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
| 06/15/2005 | EP1373240B1 Retinoid x receptor modulators |
| 06/15/2005 | EP1345609B1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 06/15/2005 | EP1330255B1 Preparation of cimicifuga racemosa for treating incontinence |
| 06/15/2005 | EP1326866B1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines |
| 06/15/2005 | EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 06/15/2005 | EP1257277B1 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent |
| 06/15/2005 | EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 06/15/2005 | EP1248610B1 Use of at least a fatty ester for preparing a composition for the therapeutic and/or cosmetic treatment of prostatic hypertrophy, prostatic adenocarcinoma, acne, hyperseborrhea, alopecia and hirsutism |
| 06/15/2005 | EP1150973B1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 06/15/2005 | EP0906108B1 Endothelin antagonists for treating heart failure |
| 06/15/2005 | CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 06/15/2005 | CN1628113A Substituted indoles as alpha-1 agonists |
| 06/15/2005 | CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
| 06/15/2005 | CN1627947A Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera |
| 06/15/2005 | CN1627946A Carboximide derivatives as useful uro-selective alpha-1A adrenoceptor blockers |
| 06/15/2005 | CN1627945A Quinoline derivatives as NPY antagonists |
| 06/15/2005 | CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones |
| 06/15/2005 | CN1626228A Extractive from decoction of rehmannia including six elements, combination of medication, and medical use |
| 06/15/2005 | CN1626210A Preparation of 'Sanjin' medication for treating diseases of urinary system and preparation method |
| 06/15/2005 | CN1626185A Capsule for treating kidney disease |
| 06/15/2005 | CN1626181A Prepared Chinese medicine for treating acute and chronic urinary infection |
| 06/15/2005 | CN1626177A Powder injection of astragalus root and preparation method |
| 06/15/2005 | CN1626172A Decoction of Chinese traditional medicine for treating disease of senile acute urine retention |
| 06/15/2005 | CN1626112A Method for preparing external and internal remedies for treating diseases of AIDS virus, burn and scald, and usage |
| 06/15/2005 | CN1626095A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 06/15/2005 | CN1626079A Fibrauretine injection preparation and preparing method |
| 06/15/2005 | CN1206338C Dog meat wine for tonifying the kidney and its preapring technique |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/15/2005 | CN1205975C Chinese medicine for treating prostatitis and its prepn. |
| 06/15/2005 | CN1205962C Formula of Chinese herbal medicine for curing lithiasis |
| 06/15/2005 | CN1205949C Externally applied ointment for treating prostatosis and its prepn |
| 06/15/2005 | CN1205935C Highly selective norepinephrine reuptake inhibitors and methods of using same |
| 06/15/2005 | CN1205930C Application of matrine oxide in preparing medicine for treating nephrotic syndrome hemorrhagic fevor |
| 06/14/2005 | US6906107 Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria |
| 06/14/2005 | US6906089 Kidney disease; cardiovascular disorders; antiscarring agents; wound healing agents |
| 06/14/2005 | US6906080 Antiinflammatory agents, analgesics, drug abuse, alcoholism |